Neurodegenerative diseases: neurotoxins as sufficient etiologic agents?
- PMID: 17985252
- PMCID: PMC2814816
- DOI: 10.1007/s12017-007-8016-8
Neurodegenerative diseases: neurotoxins as sufficient etiologic agents?
Abstract
A dominant paradigm in neurological disease research is that the primary etiological factors for diseases such as Alzheimer's (AD), Parkinson's (PD), and amyotrophic lateral sclerosis (ALS) are genetic. Opposed to this perspective are the clear observations from epidemiology that purely genetic casual factors account for a relatively small fraction of all cases. Many who support a genetic etiology for neurological disease take the view that while the percentages may be relatively small, these numbers will rise in the future with the inevitable discoveries of additional genetic mutations. The follow up argument is that even if the last is not true, the events triggered by the aberrant genes identified so far will be shown to impact the same neuronal cell death pathways as those activated by environmental factors that trigger most sporadic disease cases. In this article we present a countervailing view that environmental neurotoxins may be the sole sufficient factor in at least three neurological disease clusters. For each, neurotoxins have been isolated and characterized that, at least in animal models, faithfully reproduce each disorder without the need for genetic co-factors. Based on these data, we will propose a set of principles that would enable any potential toxin to be evaluated as an etiological factor in a given neurodegenerative disease. Finally, we will attempt to put environmental toxins into the context of possible genetically-determined susceptibility.
Figures
References
-
- Abou-Sleiman PM, Muqit MM, Wood NW. Expanding insights of mitochondrial dysfunction in Parkinson’s disease. Natural Reviews Neuroscience. 2006;7:207–219. - PubMed
-
- Albers DS, Swerdlow RH, Manfredi G, Gajewski C, Yang L, Parker WD, Jr., Beal MF. Further evidence for mitochondrial dysfunction in progressive supranuclear palsy. Experimental Neurology. 2001;168:196–198. - PubMed
-
- Angibaud G, Gaultier C, Rascol O. Annonaceae consumption in New Caledonia. Movement Disorders. 2004;19:603–604. - PubMed
-
- Ballard PA, Tetrud JW, Langston JW. Permanent human parkinsonism due to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): Seven cases. Neurology. 1985;35:949–956. - PubMed
-
- Bédlâck RS, Strittniatter WJ, Morgenlandèr JC. ApoIipoprotem E and neuromuscular disease: A critical review of the literature. Archives of Neurology. 2000;57:1561–1565. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
